Effects of prenatal exposure to perfluoroalkyl acids on prevalence ofallergic diseases among 4-year-old children

Environ Int. 2016 Sep:94:124-132. doi: 10.1016/j.envint.2016.05.020. Epub 2016 May 26.

Abstract

Perfluoroalkyl acids (PFAAs) are ubiquitous chemicals extremely resistant and widespread throughout the environment, frequently being detected in human blood samples. Animal studies have revealed that exposure to PFAAs results in immunotoxicity. However, the association between PFAAs, especially long-chain PFAAs, and allergies in humans is not well established. We examined whether prenatal exposure to PFAAs is associated with allergic diseases among 4-year-old children in a large-scale prospective birth cohort in Hokkaido, Japan. In total, 1558 mother-child pairs were included in this study and prenatal levels of eleven PFAAs were measured in maternal plasma samples obtained between 28 and 32weeks of pregnancy by using ultra-performance liquid chromatography-tandem mass spectrometry. Participant demographic and characteristic information were obtained from self-administered pre- and postnatal questionnaires and medical birth records. Infant allergies were assessed using the Japanese version of the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three questionnaire, which was administered 4years post-delivery. Symptoms included eczema, wheezing and rhinoconjunctivitis with a prevalence of 19.0%, 18.7%, and 5.4%, respectively. Associations of PFAA quartiles with allergic outcomes were examined using logistic models. Adjusted odds ratios (ORs) in the 4th quartile vs. 1st quartile (Q4 vs. Q1) for total allergic diseases (including at least one allergic outcome) significantly decreased for perfluorododecanoic acid (PFDoDa) (Q4 vs. Q1 OR: 0.621; 95% confidence interval (CI): 0.454, 0.847) and perfluorotridecanoic acid (PFTrDA) (Q4 vs. Q1 OR: 0.712; 95% CI: 0.524, 0.966) in all children. We obtained similar results when examining the association between PFAAs and eczema. The adjusted OR (Q4 vs. Q1) for wheezing in relation to higher maternal PFHxS levels was 0.728 (95% CI: 0.497, 1.06) in all children. In conclusion, prenatal exposure to long-chain PFAAs, such as PFDoDa and PFTrDA may have an immunosuppressive effect on allergic diseases in 4-year-old children.

Keywords: Allergy; Birth cohorts; Children's health; PFAAs; Prenatal exposure.

MeSH terms

  • Adult
  • Alkanesulfonic Acids / adverse effects*
  • Animals
  • Child, Preschool
  • Eczema / epidemiology
  • Environmental Pollutants / adverse effects*
  • Fatty Acids / adverse effects*
  • Female
  • Fluorocarbons / adverse effects*
  • Humans
  • Hypersensitivity / epidemiology*
  • Japan
  • Male
  • Odds Ratio
  • Pregnancy
  • Prenatal Exposure Delayed Effects*
  • Prevalence
  • Prospective Studies
  • Respiratory Sounds
  • Surveys and Questionnaires

Substances

  • Alkanesulfonic Acids
  • Environmental Pollutants
  • Fatty Acids
  • Fluorocarbons